Analysts Viewpoint Insider Sale Alert: Catalyst Pharmaceuticals Inc [CPRX] – Is it Time to sell? In a filing, Catalyst Pharmaceuticals Inc revealed its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on
Insiders Updates A Guide To The Risks Of Investing In Catalyst Pharmaceuticals Inc (CPRX) Catalyst Pharmaceuticals Inc’s filing revealed that its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on Jun
Insiders Updates CPRX short interest surges, indicating growing pessimism among investors The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or